<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noreferrer noopener" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div> 
<h3 id="key-highlights">Key Highlights</h3> 
<ul> 
 <li><strong>Revenue Growth:</strong> Medtronic reported a 6% increase in revenue, exceeding expectations with total revenue of $7.98 billion​​​​.</li> 
 <li><strong>EPS Surpasses Forecasts:</strong> Non-GAAP EPS of $1.20 was reported, outperforming the anticipated $1.18, with an increase driven by better-than-expected operational performance and favorable foreign exchange rates​​​​.</li> 
 <li><strong>Stable Margin Performance:</strong> Medtronic’s adjusted gross margin remained stable year-over-year and surpassed expectations despite inflationary pressures, contributing to an operating margin increase of 90 basis points​​​​.</li> 
</ul> 
<p>Medtronic PLC (NYSE: MDT) commenced its fiscal year 2024 with a strong start, reporting a 6% increase in revenue. The company’s total revenue reached $7.98 billion, surpassing the anticipated revenue of $7.93 billion and the previous year’s figures. This growth was notably broad-based across all four business segments and geographies, with non-US developed and Emerging Markets registering high-single-digit growth. Western Europe, in particular, showed an 8% increase, led by high-single-digit growth in Cardiovascular and Medical Surgical and high-teens growth in Diabetes​​.</p> 
<div class="cta-referral"> 
 <img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async"> 
 <div class="cta-referral__text"> 
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noreferrer noopener nofollow">Telegram group</a>&nbsp;and never miss a breaking digital asset story.</p> 
 </div> 
</div> 
<h3 id="surpassing-expectations-amidst-global-challenges">Surpassing Expectations Amidst Global Challenges</h3> 
<p>Medtronic reported a non-GAAP EPS of $1.20, 2 cents above the forecasted $1.18. This 6% increase from the previous year’s EPS was attributed to better-than-expected operational performance and a favorable impact from foreign exchange rates. These results reflect Medtronic’s ability to navigate a complex global healthcare landscape while delivering on its financial commitments and focusing on innovative healthcare solutions​​​​.</p> 
<h3 id="margin-stability-and-operational-efficiency">Margin Stability and Operational Efficiency</h3> 
<p>Despite facing inflationary pressures, Medtronic managed to maintain a stable adjusted gross margin year-over-year, exceeding expectations. This stability shows the company’s effective pricing strategies and ability to mitigate the impact of currency fluctuations. Medtronic’s operating margin also saw a notable increase of 90 basis points, driven by revenue outperformance and focused expense management, particularly in general and administrative expenses. This improvement in operating margin demonstrates Medtronic’s commitment to maintaining operational efficiency and profitability in a dynamic market environment​​​​.</p> 
<p>Medtronic PLC’s financial results for the first quarter of fiscal year 2024 illustrate a strong start to the year, with revenue growth and earnings per share surpassing expectations. The company’s ability to achieve stable margins in the face of inflationary pressures and currency fluctuations further underscores its operational efficiency and financial resilience. Medtronic’s strategic focus seems to be on diversified growth across its business segments and geographies and its capacity to adapt to global market challenges, positioning it well for ongoing success in the healthcare industry.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe> 
<p>The post <a rel="nofollow" href="https://tokenist.com/earnings-review-medtronic-beats-expectations-with-6-increase-in-revenue/">Earnings Review: Medtronic Beats Expectations with 6% Increase in Revenue</a> appeared first on <a rel="nofollow" href="https://tokenist.com">Tokenist</a>.</p>

Earnings Review: Medtronic Beats Expectations with 6% Increase in Revenue

Table of Contents

Tokenist

Other articles published on Nov 21, 2023

XRP Price Analysis for November 21

Web3 Gaming Fusionist Set to Launch ‘Fusionist Beta II’ on Steam

OpenAI Staff Tells Board To Resign After Sam Altman Ousting

Blackmail Thwarts $90K ‘Hostile Governance Attack’ On Indexed Finance DAO

Libertum Launches Innovative Real Estate Investment Platform: Democratizing Property Investment

Is It Too Late To Buy Crypto? Raoul Pal Weighs In

Join our free newsletter for daily crypto updates!